SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,638 | -75.7% | 24,405 | -47.4% | 0.00% | – |
Q2 2023 | $60,330 | +179.8% | 46,408 | +278.8% | 0.00% | – |
Q1 2023 | $21,561 | -26.9% | 12,251 | +30.5% | 0.00% | – |
Q4 2022 | $29,481 | -41.0% | 9,389 | -8.0% | 0.00% | – |
Q3 2022 | $50,000 | +56.2% | 10,205 | +31.5% | 0.00% | – |
Q2 2022 | $32,000 | -93.0% | 7,760 | -90.1% | 0.00% | -100.0% |
Q1 2022 | $457,000 | -37.7% | 78,705 | -19.5% | 0.00% | 0.0% |
Q4 2021 | $733,000 | – | 97,778 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |